Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. IBM
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to Theravance Biopharma, Inc. Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Tops Q4 EPS by 10c, Revenues Miss

February 23, 2021 4:42 PM EST

Theravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($0.92), $0.10 better than the analyst estimate of ($1.02). Revenue for the quarter came in at $18.7 million versus the consensus estimate of $20.85 million.

"2020 was a critical year of growth for YUPELRI, with our commercial team persevering during a respiratory... More